首页> 外文期刊>Modern Pathology >MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells
【24h】

MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells

机译:MALT淋巴瘤中的MALT1和BCL10畸变及其对肿瘤细胞中BCL10表达的影响

获取原文
           

摘要

Among the genetic abnormalities reported to occur in mucosa-associated lymphoid tissue (MALT) lymphomas, the three translocations t(11;18)(q21;q21), t(1;14)(p22;q32) and t(14;18)(q32;q21) are of particular interest because they appear to be specific for, or at least closely related to this type of B-cell non-Hodgkin's lymphoma. These translocations affect the MALT1 (18q21) and BCL10 (1p22) genes. We retrieved 77 consecutive biopsies of MALT lymphomas (documented with frozen material) over a 10-year period and investigated these cases for the presence of these three translocations with fluorescence in situ hybridisation, along with the immunohistochemical analysis of the intracellular localisation of the BCL10 protein. The above-listed translocations occurred mutually exclusive and were detected in 10, 1 and 3% of the cases, respectively (the latter incidence being much lower than in the previously reported studies by one single group). These genetic rearrangements corresponded well with the aberrant subcellular localisation of the BCL10 protein as found by immunohistochemistry: t(11;18)(q21;q21) and (1;14)(p22;q32) were marked by a, respectively, moderate to strong nuclear BCL10 staining pattern while t(14;18)(q32;q21)-positive MALT lymphomas were characterised by a perinuclear BCL10 staining pattern. This study further supports the close interaction between the MALT1 and BCL10 proteins in the pathogenesis of MALT lymphomas and may indicate that BCL10 immunohistochemistry is a simple technique to identify those MALT lymphoma cases with an underlying genetic aberration.
机译:在据报道发生在粘膜相关淋巴样组织(MALT)淋巴瘤的遗传异常中,三个易位t(11; 18)(q21; q21),t(1; 14)(p22; q32)和t(14; 18) (q32; q21)特别令人感兴趣,因为它们似乎对这种B细胞非霍奇金淋巴瘤具有特异性或至少与之密切相关。这些易位影响MALT1(18q21)和BCL10(1p22)基因。我们在10年的时间内检索了77份MALT淋巴瘤的连续活检(记录有冷冻材料),并通过荧光原位杂交以及BCL10蛋白在细胞内定位的免疫组织化学分析,调查了这些病例中这三个易位的存在。上面列出的易位是互斥的,分别在10%,1%和3%的病例中被检测到(后者的发生率比以前报道的单个组低得多)。这些遗传重排与免疫组织化学发现的BCL10蛋白异常的亚细胞定位非常吻合:t(11; 18)(q21; q21)和(1; 14)(p22; q32)分别用a标记,中等至t(14; 18)(q32; q21)阳性MALT淋巴瘤以核周BCL10染色为特征,而t(14; 18)(q32; q21)阳性的MALT淋巴瘤为强核BCL10染色。这项研究进一步支持MALT1和BCL10蛋白在MALT淋巴瘤的发病机理中的密切相互作用,并可能表明BCL10免疫组织化学是鉴定具有潜在遗传异常的MALT淋巴瘤病例的简单技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号